Early maternal deprivation as an animal model for schizophrenia

被引:61
作者
Ellenbroek, BA
Riva, MA
机构
[1] Univ Nijmegen, Dept Psychoneuropharmacol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Milan, Dept Pharmacol Sci, Ctr Neuropharmacol, Milan, Italy
[3] Univ Milan, Ctr Excellence Neurodegenerat Disorders, Milan, Italy
关键词
maternal deprivation; schizophrenia; animal model; brain derived neurotrophic factor; prepulse inhibition; hippocampus;
D O I
10.1016/S1566-2772(03)00090-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Since the aetiology and the neuropathology of schizophrenia still largely eludes us, the development of animal models for this severe psychiatric disease has remained a difficult undertaking. As a consequence of this, there is no 'best' animal model for schizophrenia. Nonetheless, the models which focus on the neurodevelopmental hypothesis have so far been the most successful. One of these is the maternal deprivation (MD) model in which young rats are separated from their mothers for a single period of 24 hr. The present paper gives an overview of the current knowledge on this model. It appears that MD at postnatal day 9 leads to a large variety of behavioural changes (such as a disruption in prepulse inhibition, latent inhibition, acoustic sensory gating and startle habituation) which closely resemble the symptoms of schizophrenia. Moreover, MD leads to neurochemical changes, predominantly in the hippocampal formation, suggestive of a reduced plasticity. Overall it appears that MD represents an interesting animal model for investigating the deleterious effects of early stressful life events, with special emphasis on possible schizophrenia-like characteristics. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 74 条
  • [1] ADLER LE, 1982, BIOL PSYCHIAT, V17, P649
  • [2] Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia
    Agid, O
    Shapira, B
    Zislin, J
    Ritsner, M
    Ritsner, M
    Hanin, B
    Murad, H
    Troudart, T
    Bloch, M
    Heresco-Levy, U
    Lerer, B
    [J]. MOLECULAR PSYCHIATRY, 1999, 4 (02) : 163 - 172
  • [3] Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions
    Angelucci, F
    Aloe, L
    Gruber, SHM
    Fiore, M
    Mathé, AA
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2000, 3 (01) : 13 - 25
  • [4] ARSENEAULT L, 2003, BRIT MED J, V325, P1212
  • [5] Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs
    Bai, O
    Chlan-Fourney, J
    Bowen, R
    Keegan, D
    Li, XM
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 71 (01) : 127 - 131
  • [6] DECREASED EXPRESSION OF THE EMBRYONIC FORM OF THE NEURAL CELL-ADHESION MOLECULE IN SCHIZOPHRENIC BRAINS
    BARBEAU, D
    LIANG, JJ
    ROBITAILLE, Y
    QUIRION, R
    SRIVASTAVA, LK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) : 2785 - 2789
  • [7] DIFFERENTIAL PERFORMANCE OF ACUTE AND CHRONIC-SCHIZOPHRENICS IN A LATENT INHIBITION TASK
    BARUCH, I
    HEMSLEY, DR
    GRAY, JA
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1988, 176 (10) : 598 - 606
  • [8] Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "Two hit hypothesis"
    Bayer, TA
    Falkai, P
    Maier, W
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1999, 33 (06) : 543 - 548
  • [9] Black IB, 1999, J NEUROBIOL, V41, P108, DOI 10.1002/(SICI)1097-4695(199910)41:1<108::AID-NEU14>3.0.CO
  • [10] 2-U